Latest Metastasis Stories

Study clarifies roles of anti-angiogenic proteins in discouraging metastasis and reveals potential anti-metastasis drug BOSTON, May 21, 2013 /PRNewswire-USNewswire/ -- By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer. The findings suggest that...

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, will host the 8th annual “Sounding Off For A Cure” Benefit Concert featuring The Wailers. New York, NY (PRWEB) May 16, 2013 On May 16, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, will host its 8th Annual “Sounding Off For A Cure” benefit concert on Thursday, June 6, 2013 at The Hammerstein in New York City at 6:00 PM. The concert is...

WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Xofigo(®) (radium Ra 223 dichloride) for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastatic disease. Xofigo is the first and only alpha particle-emitting radioactive therapeutic agent approved by the FDA that has demonstrated...

Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of vessels that transports and stores immune cells throughout the body – to promote the spread of disease, a process called metastasis. The findings are published in this week's online Early Edition of the Proceedings of the National Academy of Sciences. Roughly 90 percent of all cancer deaths...

METASTASIS Developed For Latin America CULVER CITY, Calif. and MIAMI, May 13, 2013 /PRNewswire/ -- Sony Pictures Television (SPT) and Teleset have announced that they will produce an original series adaptation of the smash hit U.S. drama "Breaking Bad" for Latin American audiences. "Metastasis" is the first adaptation of the award-winning series by SPT, a pioneer and industry leader in scripted formats. The show has been cleared in most major Spanish-speaking markets including...

An international group of investigators, led by researchers at Thomas Jefferson University's Kimmel Cancer Center, have solved the mystery of why a substantial percentage of castrate-resistant metastatic prostate cancer cells contain abnormally high levels of the pro-growth protein Stat5. They discovered that the gene that makes the protein is amplified — duplicated many times over — in these cancer cells, which allows them to produce excess amounts of the oncogenic protein. The study,...

Two Johns Hopkins University School of Medicine studies presented at the 2013 AUA Annual Meeting demonstrate Decipher's ability to outperform existing tools for predicting metastasis and disease progression SAN DIEGO, May 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for the American Urological Association demonstrated that Decipher(TM), a transformative genomic...

Revenues Continue to Ramp in 2013 IRVINE, Calif., May 2, 2013 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that it has reported more than 20,000 MammaPrint breast cancer results, including approximately 6,000 in 2012 alone. The MammaPrint test analyzes 70 key genes and accurately determines which patients are at low risk of breast cancer recurrence and can therefore safely choose not to undergo chemotherapy. Case volume grew by more than...

Cancer cells are wily, well-traveled adversaries, constantly side-stepping treatments to stop their spread. But for the first time, scientists at the University of Michigan have decoded the molecular chatter that ramps certain cancer cells into overdrive and can cause tumors to metastasize throughout the body. Researchers have long known that tumors recruit healing cells, which is a major reason why cancer is so difficult to thwart. This is the first known study to explain the molecular...

Injection of human stem cells into mice with tumors slowed down tumor growth, finds research published in BioMed Central's open access journal Stem Cell Research & Therapy. Human mesenchymal stem cells (MSC), isolated from bone marrow, caused changes in blood vessels supplying the tumor, and it is this modification of blood supply which seems to impact tumor growth. The use of stem cells in treating cancer has been controversial, with some studies finding that stem cells force tumors...